Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Current Assets (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Current Assets data on record, last reported at $113.6 million in Q4 2025.

  • For Q4 2025, Current Assets rose 17.84% year-over-year to $113.6 million; the TTM value through Oct 2025 reached $113.6 million, up 17.84%, while the annual FY2025 figure was $118.4 million, 22.25% up from the prior year.
  • Current Assets reached $113.6 million in Q4 2025 per KEQU's latest filing, down from $118.4 million in the prior quarter.
  • Across five years, Current Assets topped out at $118.4 million in Q2 2025 and bottomed at $60.1 million in Q1 2021.
  • Average Current Assets over 5 years is $91.5 million, with a median of $92.1 million recorded in 2022.
  • Peak YoY movement for Current Assets: skyrocketed 51.45% in 2022, then dropped 3.98% in 2023.
  • A 5-year view of Current Assets shows it stood at $60.5 million in 2021, then surged by 61.74% to $97.8 million in 2022, then decreased by 7.06% to $90.9 million in 2023, then rose by 6.12% to $96.4 million in 2024, then grew by 17.84% to $113.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $113.6 million in Q4 2025, $118.4 million in Q2 2025, and $96.4 million in Q4 2024.